This site is intended for healthcare professionals
Micrograph of bone marrow rendered in pinks and purples

Find disease awareness content and relevant supporting materials

    Learning Zone CME Events News Trials Guidelines Journals
    Filter results
    Sort by:
    Relevance
    to
    Guidelines
    Guideline
    01/03/22

    British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021

    The British Association of Dermatologists guidelines for managing chronic urticaria provide evidence-based recommendations for treatment across primary, secondary, and tertiary care. The guidelines include practical clinical questions and updated patient information.

    • Source: British Association of Dermatologists (BAD)
    Journals
    Journal
    19/09/19

    Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications

    Chronic urticaria (CU) is a mast cell-driven disease characterized by the development of wheals, angioedema, or both for more than 6 weeks. The two major sub-types are chronic spontaneous urticaria (CSU) and inducible urticaria.

    • Source: Journal of Asthma and Allergy
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    21/06/17

    AWARE real world study of 3,733 chronic urticaria (CU) patients shows inadequate care.

    Novartis announced new baseline results from a real world study of 3,733 chronic urticaria (CU) patients showing many are not...

    Guidelines
    Guideline
    01/03/22

    The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

    The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline provides comprehensive recommendations for the definition, classification, diagnosis, and management of urticaria. This guideline is based on evidence and consensus from experts across multiple organizations.

    • Source: European Academy of Allergy & Clinical Immunology (EAACI), Global Allergy and Asthma European Network (GA²LEN), European Dermatology Forum (EDF; EuroGuiDerm), Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAACI)
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    07/03/18

    Guideline recommends Xolair to treat chronic urticaria.- Novartis.

    A new global guideline on chronic urticaria (CU) recommends Xolair (omalizumab), indicated as add-on therapy for the treatment of chronic...

    Journals
    Journal
    01/05/19

    Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study

    Objective: To describe disease burden, quality of life (QoL), and treatment patterns of patients with H1 antihistamine refractory CSU in Germany.

    • Source: Clinical & Experimental Allergy
    Journals
    Journal
    01/08/23

    Nine cases of chronic hand and foot eczema treated with baricitinib

    Chronic hand and foot eczema (CHFE) is a common inflammatory disorder that generally lasts for over 3 months.

    • Source: Australasian Journal of Dermatology
    Guidelines
    Guideline
    01/01/22

    EAACI Biologicals Guidelines - Omalizumab for the treatment of CSU in adults and in the paediatric population 12–17 years old

    The EAACI Biologicals Guidelines for the treatment of chronic spontaneous urticaria (CSU) with omalizumab provide a comprehensive approach to managing this condition. The guidelines address practical issues such as responder selection, treatment duration, and cost-effectiveness.

    • Source: European Academy of Allergy & Clinical Immunology (EAACI)
    Journals
    Journal
    01/01/10

    Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis

    The effectiveness of corticosteroids in antihistamine-resistant chronic urticaria (CU) is widely accepted although large studies on their use in this disease are lacking.

    • Source: Journal of Investigational Allergology and Clinical Immunology
    Journals
    Journal
    01/02/21

    Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative

    Chronic hand/foot eczemas are common, but treatment is often challenging, with widespread dissatisfaction over current available options. Detailed history is important, particularly with regard to potential exposure to irritants and allergens.

    • Source: Australasian Journal of Dermatology
    See more